Nedaplatin - CAS 95734-82-0
Catalog number: 95734-82-0
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C2H8N2O3Pt
Molecular Weight:
303.17
COA:
Inquire
Targets:
Others
Description:
Nedaplatin is a derivative of cisplatin and DNA damage agent for tumor colony forming units with IC50 of 94 μM.
Publictions citing BOC Sciences Products
  • >> More
Purity:
>98%
MSDS:
Inquire
1.Phase I trial of nedaplatin chemotherapy concurrent with radiotherapy for untreated locoregionally advanced nasopharyngeal carcinoma.
Liang Z1,2, Wang S2, Lin Z3, Feng S4, Cheng Z2, Yang Y1, Kuang Y1, Fidelis C1, Ullah S1, Li F5,6. Cancer Chemother Pharmacol. 2016 Mar;77(3):643-51. doi: 10.1007/s00280-016-2971-4. Epub 2016 Jan 30.
PURPOSE: In this phase I study, single-agent chemotherapy was conducted in patients with locoregionally advanced nasopharyngeal carcinoma (NPC) using nedaplatin (NDP) and concomitant radiotherapy. The study sought to determine the maximum tolerated dose (MTD), recommended dose (RD) and the clinical efficacy of this treatment in locoregionally advanced NPC patients.
2.The role of the equatorial ligands for the redox behavior, mode of cellular accumulation and cytotoxicity of platinum(IV) prodrugs.
Göschl S1, Varbanov HP2, Theiner S3, Jakupec MA4, Galanski M1, Keppler BK3. J Inorg Biochem. 2016 Mar 17. pii: S0162-0134(16)30069-1. doi: 10.1016/j.jinorgbio.2016.03.005. [Epub ahead of print]
The current study aims to elucidate the possible reasons for the significantly different pharmacological behavior of platinum(IV) complexes with cisplatin-, carboplatin- or nedaplatin-like cores and how this difference can be related to their main physicochemical properties. Chlorido-containing complexes are reduced fast (within hours) by ascorbate and are able to unwind plasmid DNA in the presence of ascorbate, while their tri- and tetracarboxylato analogs are generally inert under the same conditions. Comparison of the lipophilicity, cellular accumulation and cytotoxicity of the investigated platinum compounds revealed the necessity to define new structure-property/activity relationships (SPRs and SARs). The higher activity and improved accumulation of platinum(IV) complexes bearing Cl- in equatorial position cannot only be attributed to passive diffusion facilitated by their lipophilicity. Therefore, further platinum accumulation experiments under conditions where active/facilitated transport mechanisms are suppressed were performed.
3.Phase II trial of neoadjuvant chemotherapy with docetaxel, nedaplatin, and S1 for advanced esophageal squamous cell carcinoma.
Tanaka Y1, Yoshida K1, Tanahashi T1, Okumura N1, Matsuhashi N1, Yamaguchi K1. Cancer Sci. 2016 Apr 7. doi: 10.1111/cas.12943. [Epub ahead of print]
Although standard chemotherapy for esophageal cancer patients is fluorouracil and cisplatin (FP), the prognosis is still unsatisfactory. A new therapeutic regimen combining docetaxel, cisplatin, and 5-Fu (DCF) was recently developed to improve both local and distant tumor control. We developed a new regimen of docetaxel, nedaplatin, and S1 (DGS) and previously reported the recommended dose in a Phase I dose-escalation study. We then performed a phase II study of DGS for advanced esophageal squamous cell carcinoma (SCC). Patients with clinical stage II/III were eligible. Patients received two courses of chemotherapy: docetaxel 35 mg/m2 with nedaplatin 40 mg/m2 on day 8, 80 mg/m2 S1 on days 1-14, and 2 weeks off. After completion of chemotherapy, patients underwent esophagectomy. The primary endpoint was the completion rate of protocol treatment (completion of two courses of preoperative chemotherapy and R0 surgery). We enrolled 32 patients.
4.Nedaplatin sensitization of cisplatin-resistant human non-small cell lung cancer cells.
Wang H1, Zhu X1, Huang J1, Chen P2, Han S1, Yan X1. Oncol Lett. 2016 Apr;11(4):2566-2572. Epub 2016 Feb 24.
Cisplatin (DDP) has been one of the most widely used chemotherapy drugs for advanced non-small cell lung cancer. However, the increase in the number of DDP-resistant cancer cells has become a major impediment in the clinical management of cancer. In the present study, for the first time, the 3-(4,5-dimethylthiazol-2yl)-2,5-diphenyltetrazolium bromide assay was used to demonstrate that nedaplatin (NDP) could have a stronger inhibitory effect than DDP alone in DDP-resistant A549 (A549DDP) cells and that it could attenuate the resistance of these cells. Additionally, flow cytometry analysis showed that the apoptosis rate of these resistant cells when exposed to NDP was markedly increased and the number of cells in the G2 stage of the cell cycle was significantly increased. Furthermore, western blot analysis indicated that NDP decreased the protein expression of P-glycoprotein, tumor protein p53 and B-cell lymphoma 2, and increased the expression of Bcl-2-associated X protein, all of which could possibly improve the NDP intracellular drug concentration and promote cell apoptosis.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Products


CAS 86170-12-9 CGP 23996

CGP 23996
(CAS: 86170-12-9)

CGP 23996 is a non-reducible somatostatin analog. It can be used for autoradiography.

CAS 202914-84-9 Lomitapide Mesylate

Lomitapide Mesylate
(CAS: 202914-84-9)

Lomitapide Mesylate is a potent microsomal triglyceride transfer protein (MTP) inhibitor, used in the treatment of familial hypercholesterolemia.

CAS 61276-17-3 Verbascoside

Verbascoside
(CAS: 61276-17-3)

Verbascoside is a bioactive polyphenol from olive oil mill wastewater with known antioxidant activity, which is a protein kinase C inhibitor.

CAS 11088-09-8 Wilforine

Wilforine
(CAS: 11088-09-8)

Wilforine, a sesquiterpene pyridine alkaloid, is effective in treating idiopathic pulmonary fibrosis.

APCP-363
(CAS: 340023-40-7)

APCP-363 a bio-active chemical.

CAS 23651-95-8 Droxidopa

Droxidopa
(CAS: 23651-95-8)

Droxidopa(L-DOPS, SM5688) is a synthetic amino acid precursor which acts as a prodrug to the neurotransmitters norepinephrine (noradrenaline) and epinephrine (a...

CAS 9041-93-4 Bleomycin sulfate

Bleomycin sulfate
(CAS: 9041-93-4)

Bleomycin sulfate is a mixture of the sulfate salts of basic glycopeptide antineoplastic antibiotics isolated from Streptomyces verticillus. Bleomycin sulfate ...

MDL-72274 HCl
(CAS: 85278-24-6)

MDL-72274 is a selective SSAO inhibitor. It is a potent (IC50 = 10(-9) M) inhibitor of both MAO-B and SSAO, with 190-fold lower affinity for MAO-A. MDL-72974 ca...

CAS 151126-32-8 Pramlintide

Pramlintide
(CAS: 151126-32-8)

Pramlintide, a synthetic version of amylin, is the first in a new class of pharmaceutical agents and exhibits high affinity for amylin, CGRP and calcitonin rece...

CAS 137-08-6 Calcium D-Panthotenate

Calcium D-Panthotenate
(CAS: 137-08-6)

Calcium D-Panthotenate, also called vitamin B5 Calcium, is a water-soluble vitamin and an essential nutrient for many animals.

CAS 312-63-0 ELN 484228

ELN 484228
(CAS: 312-63-0)

ELN 484228 is an α-Synuclein blocker with activity in cellular models of α-synuclein-mediated dysfunction such as Parkinson’s Disease. Study showed that ELN4842...

CAS 1173022-21-3 STO-609 acetate

STO-609 acetate
(CAS: 1173022-21-3)

STO-609 acetate is a selective and cell-permeable inhibitor of Ca2+-calmodulin-dependent protein kinase kinase (CaMKK) (Ki = 80 and 15 ng/ml for inhibition of C...

ABT116
(CAS: 1008529-42-7)

ABT116 is an antagonist of transient receptor potential vanilloid type 1.

BMS-505130
(CAS: 859230-84-5)

BMS-505130 is a selective serotonin transport inhibitor with Ki of 0.18 nM. Ki value for binding to the norepinephrine is 4.6 mM and for dopamine transporters i...

CAS 1800025-30-2 MGAT2-IN-1

MGAT2-IN-1
(CAS: 1800025-30-2)

An orally active inhibitor of monoacylglycerol acyltransferase (MGAT2) (IC50= 7.8 for human, and 2.4 nM for mouse MGAT2).

CAS 14197-60-5 Ginsenoside Rg3

Ginsenoside Rg3
(CAS: 14197-60-5)

Ginsenoside Rg3 is a natural product isolated from Panax ginseng. Similar to other ginsenosides it exhibits cardio protective effects. Ginsenoside Rg3 enhances ...

CAS 88898-17-3 Atrial natriuretic factor (1-28) (rat)

Atrial natriuretic factor (1-28) (rat)
(CAS: 88898-17-3)

Atrial natriuretic factor (1-28) (rat) is a 28 amino acid peptide corresponding to the rat protein sequence. It is an endogenous peptide synthesized in myoendoc...

CAS 71610-00-9 Cephalomannine

Cephalomannine
(CAS: 71610-00-9)

Cephalomannine is an active anti-cancer agent obtained from Taxus yunnanensis and has an antineoplastic effect on tumors found in mice.

CAS 300586-90-7 OAC1

OAC1
(CAS: 300586-90-7)

OAC1 is a Octamer-binding transcription factor 4 (Oct4)-activating compound; enhances the iPSC reprogramming efficiency and accelerated the reprogramming proces...

VRX-806
(CAS: 1004523-72-1)

VRX-806 is a novel nonnucleoside reverse transcriptase inhibitor (NNRTI) with potent in vitro activity against wild-type and NNRTI-resistant HIV-1.

Chemical Structure

CAS 95734-82-0 Nedaplatin

Quick Inquiry

Verification code

Featured Items